GLP-1 agonists1 help the pancreas release insulin, reduce excess glucagon (a hormone that raises blood sugar) , slow down digestion, and signal the brain to increase fullness and reduce hunger
These effects are most pronounced during dose escalation and typically diminish over time as your body adjusts to the medication
Sjogren's syndrome Sjogren's syndrome, characterized by autoimmune destruction of moisture-producing glands causing dry eyes and dry mouth, has a complex relationship with metabolic health
Bayes-Genis A et al (2025) Remote pulmonary artery pressure-guided management of patients with heart failure: a clinical consensus statement of the heart failure association (HFA) of the ESC, (in eng)
Speakers : Dalal Hammoudi (EMR) , Miranda Sertic (Eur) , Amanda Cavness (USA), Rajani Shakya (SEA), Andreia Bruno-Tome, Aust (WP), Mariam Gyasi (AFR), Maram Haj Ahmad (EMR) Future-focused dialogue From inspiration to action: Moderators : Vibhuti Arya, Mariet Eksteen